Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lior Nesher

Showing results (31-40 of 78) with videos related to

Pageof 8
Sort By:
The Journal of Antibiotics|May 15, 2014
In vitro activity of telavancin compared with vancomycin and linezolid against Gram-positive organisms isolated from cancer patientsKenneth Rolston, Weiqun Wang, Lior Nesher, et al.
Jac-Antimicrobial Resistance|March 6, 2023
<i>In vitro</i> activity of eravacycline and comparator agents against bacterial pathogens isolated from patients with cancerKenneth Rolston, Bahgat Gerges, Lior Nesher, et al.
The Journal of Antibiotics|December 3, 2015
In vitro activity of dalbavancin and five comparator agents against common and uncommon Gram-positive organisms isolated from cancer patientsKenneth V I Rolston, Weiqun Wang, Lior Nesher, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|October 8, 2025
Respiratory Syncytial Virus Exceeded SARS-CoV-2 and Influenza in Lower Respiratory Infection and Mortality Rates Among Patients With Hematologic Malignancies During the 2023-2024 Respiratory Virus SeasonTali Shafat, Amy Spallone, Fareed Khawaja, et al.
Infection Control and Hospital Epidemiology|October 28, 2025
Legionella on tap: nosocomial pneumonia cluster linked to a hospital cold water dispenser in hematology patientsOren Biham, Hovav Azulay, Ronit Nativ, et al.
International Journal of Antimicrobial Agents|April 30, 2023
Beating the clock: Reduced time to first antibiotic dose administration following an audit and feedback interventionTal Schlaeffer-Yosef, Tali Shafat, Jacob Dreiher, et al.
Spectrochimica Acta. Part A, Molecular and Biomolecular Spectroscopy|March 21, 2023
Detection of extended-spectrum β-lactamase-producing bacteria isolated directly from urine by infrared spectroscopy and machine learningGeorge Abu-Aqil, Manal Suleiman, Uraib Sharaha, et al.
Diagnostic Microbiology and Infectious Disease|January 23, 2017
Time-kill determination of the bactericidal activity of telavancin and vancomycin against clinical methicillin-resistant Staphylococcus aureus isolates from cancer patientsKenneth Vi Rolston, Weiqun Wang, Lior Nesher, et al.
Antibiotics (Basel, Switzerland)|February 13, 2021
Impact of an Antibiotic Stewardship Program on the Incidence of Resistant <i>Escherichia coli</i>: A Quasi-Experimental StudyElad Ziv-On, Michael D Friger, Lisa Saidel-Odes, et al.
The International Journal of Lower Extremity Wounds|April 11, 2022
Multifaceted Strategy Improves Outcomes of Patients Hospitalized with a Diabetic Foot InfectionElad Keren, Abraham Borer, Tali Shafat, et al.
Pageof 8

Showing results (31-40 of 78) with videos related to

Sort By:
Pageof 8
The Journal of Antibiotics|May 15, 2014
In vitro activity of telavancin compared with vancomycin and linezolid against Gram-positive organisms isolated from cancer patientsKenneth Rolston, Weiqun Wang, Lior Nesher, et al.
Jac-Antimicrobial Resistance|March 6, 2023
<i>In vitro</i> activity of eravacycline and comparator agents against bacterial pathogens isolated from patients with cancerKenneth Rolston, Bahgat Gerges, Lior Nesher, et al.
The Journal of Antibiotics|December 3, 2015
In vitro activity of dalbavancin and five comparator agents against common and uncommon Gram-positive organisms isolated from cancer patientsKenneth V I Rolston, Weiqun Wang, Lior Nesher, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|October 8, 2025
Respiratory Syncytial Virus Exceeded SARS-CoV-2 and Influenza in Lower Respiratory Infection and Mortality Rates Among Patients With Hematologic Malignancies During the 2023-2024 Respiratory Virus SeasonTali Shafat, Amy Spallone, Fareed Khawaja, et al.
Infection Control and Hospital Epidemiology|October 28, 2025
Legionella on tap: nosocomial pneumonia cluster linked to a hospital cold water dispenser in hematology patientsOren Biham, Hovav Azulay, Ronit Nativ, et al.
International Journal of Antimicrobial Agents|April 30, 2023
Beating the clock: Reduced time to first antibiotic dose administration following an audit and feedback interventionTal Schlaeffer-Yosef, Tali Shafat, Jacob Dreiher, et al.
Spectrochimica Acta. Part A, Molecular and Biomolecular Spectroscopy|March 21, 2023
Detection of extended-spectrum β-lactamase-producing bacteria isolated directly from urine by infrared spectroscopy and machine learningGeorge Abu-Aqil, Manal Suleiman, Uraib Sharaha, et al.
Diagnostic Microbiology and Infectious Disease|January 23, 2017
Time-kill determination of the bactericidal activity of telavancin and vancomycin against clinical methicillin-resistant Staphylococcus aureus isolates from cancer patientsKenneth Vi Rolston, Weiqun Wang, Lior Nesher, et al.
Antibiotics (Basel, Switzerland)|February 13, 2021
Impact of an Antibiotic Stewardship Program on the Incidence of Resistant <i>Escherichia coli</i>: A Quasi-Experimental StudyElad Ziv-On, Michael D Friger, Lisa Saidel-Odes, et al.
The International Journal of Lower Extremity Wounds|April 11, 2022
Multifaceted Strategy Improves Outcomes of Patients Hospitalized with a Diabetic Foot InfectionElad Keren, Abraham Borer, Tali Shafat, et al.
Pageof 8